Prof. B. Leufkens, PharmD, PhD

Utrecht Institute for Pharmaceutical Sciences (UIPS) and Dutch Medicines Evaluation Board (MEB)

Speaker Module A & D

Bert Leufkens obtained his PharmD and PhD degree from Utrecht University. During the mid-80s he worked at Leiden University and was a Fulbright Fellow at the University of Minnesota (US). In 1997 he was appointed as full professor of Pharmacoepidemiology at Utrecht University. From 2003-2005 he was the Scientific Director of the Utrecht Institute for Pharmaceutical Sciences (UIPS), and during 2006-2007 Head of the Depart­ment of Pharmaceutical Sciences of the Faculty of Science in Utrecht. In 2007 he was appointed as Chair of Dutch Medicines Evaluation Board (MEB). Dr Leufkens is research and policy-wise active at several (inter)national platforms on pharmaco­epidemiology (e.g. past co-opted member for pharma­co­­epidemiology of the EMA CHMP 2009-2015, past-Pre­si­dent of ISPE), pharmaco­vigilance (past-member EMA Pharmaco­vigilance Working Party), orphan drugs (past-Chairman of the Dutch Steering Committee on Orphan Drugs), pharma policy (since 2008 Scientific Director of the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation), regulatory science and scenario planning. He is (co) author of >450 papers in peer reviewed journals, book chapters and research reports.